Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amicus Therapeutics Ramps Up Gene Therapy Portfolio with Acquisition of 10 Programs
Amicus Therapeutics Ramps Up Gene Therapy Portfolio with Acquisition of 10 Programs
Amicus Therapeutics Ramps Up Gene Therapy Portfolio with Acquisition of 10 Programs
Submitted by
admin
on September 20, 2018 - 9:46am
Source:
CP Wire
News Tags:
Amicus Therapeutics
gene therapy
Batten disease
Headline:
Amicus Therapeutics Ramps Up Gene Therapy Portfolio with Acquisition of 10 Programs
snippet:
Amicus will make an upfront cash payment of $100 million
The company also announced closing a $150 million term loan to help finance the acquisition and development costs
Lead programs are for three forms of Batten disease
Do Not Allow Advertisers to Use My Personal information
